Citations (97)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (29)
Estelle Watson, Akash Khandelwal, Jan Freijer, John van den Anker, Claudia Lefeber & Mariëlle Eerdekens. (2019) Population pharmacokinetic modeling to facilitate dose selection of tapentadol in the pediatric population. Journal of Pain Research 12, pages 2835-2850.
Read now
Read now
Christoph Beuter, Gisela Volkers, Tatjana Radic, Jutta Goldberg & John van den Anker. (2019) Efficacy and safety of multiple doses of tapentadol oral solution in the treatment of moderate to severe acute pain in children aged 2 to <18 years – a randomized, double-blind, placebo-controlled trial. Journal of Pain Research 12, pages 3099-3112.
Read now
Read now
Julia C Finkel, Jutta Goldberg, Ronald Rosenburg, Jay Ariyawansa, Tao Sun, Rachel Ochs-Ross, Peter Zannikos, Liping Zhang & Mila Etropolski. (2019) First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18. Journal of Pain Research 12, pages 1925-1936.
Read now
Read now
Derek Muse, Eva Tarau, Claudia Lefeber, Melanie Sohns, Martin Brett, Jutta Goldberg & Ronald Rosenburg. (2019) Pharmacokinetics, safety, and efficacy of tapentadol oral solution for treating moderate to severe pain in pediatric patients. Journal of Pain Research 12, pages 1777-1790.
Read now
Read now
Joseph V. Pergolizzi$suffix/text()$suffix/text(), Jo Ann LeQuang, Robert Taylor$suffix/text()$suffix/text(), Michael H. Ossipov, Daniel Colucci & Robert B. Raffa. (2018) Designing safer analgesics: a focus on μ-opioid receptor pathways. Expert Opinion on Drug Discovery 13:10, pages 965-972.
Read now
Read now
Laura E. Gressler, Drayton A. Hammond & Jacob T. Painter. (2017) Serotonin Syndrome in Tapentadol Literature: Systematic Review of Original Research. Journal of Pain & Palliative Care Pharmacotherapy 31:3-4, pages 228-236.
Read now
Read now
Bruce D Nicholson. (2017) Economic and clinical burden of opioid-induced nausea and vomiting. Postgraduate Medicine 129:1, pages 111-117.
Read now
Read now
M. Förster, S. Helfert, R. Dierschke, M. Großkopf, P. Hüllemann, T. Keller, R. Baron & A. Binder. (2016) Evaluation of the antihyperalgesic effect of tapentadol in two human evoked pain models – the TapCapMentho pilot trial. Expert Opinion on Pharmacotherapy 17:13, pages 1717-1725.
Read now
Read now
Yeung-Jen Chen, Chao-Ching Chiang, Peng-Ju Huang, Jason Huang, Keith Karcher & Honglan Li. (2015) Tapentadol immediate-release for acute postbunionectomy pain: a phase 3, randomized, double-blind, placebo-controlled, parallel-group study in Taiwan. Current Medical Research and Opinion 31:11, pages 2001-2009.
Read now
Read now
Nebojsa Nick Knezevic, Tatiana Tverdohleb, Ivana Knezevic & Kenneth D Candido. (2015) Unique pharmacology of tapentadol for treating acute and chronic pain. Expert Opinion on Drug Metabolism & Toxicology 11:9, pages 1475-1492.
Read now
Read now
K. Kostev, F. Wartenberg, H. Richter, M. Reinwald & C. Heilmaier. (2015) Persistence with opioid treatment in Germany in patients suffering from chronic non-malignant or cancer pain. Current Medical Research and Opinion 31:6, pages 1157-1163.
Read now
Read now
Yong-Beom Park, Chul-Won Ha, Sung-Do Cho, Myung-Chul Lee, Ju-Hong Lee, Seung-Suk Seo, Seung-Baik Kang, Hee-Soo Kyung, Choong-Hyeok Choi, NaYoon Chang, Hyou Young (Helen) Rhim & Seong-Il Bin. (2015) A randomized study to compare the efficacy and safety of extended-release and immediate-release tramadol HCl/acetaminophen in patients with acute pain following total knee replacement. Current Medical Research and Opinion 31:1, pages 75-84.
Read now
Read now
Charles V. Pollack$suffix/text()$suffix/text() & Eugene R. Viscusi. (2015) Improving acute pain management in emergency medicine. Hospital Practice 43:1, pages 36-45.
Read now
Read now
Neil Singla, Thomas Barrett, Lisa Sisk, Kenneth Kostenbader & Jim Young. (2014) Assessment of the safety and efficacy of extended-release oxycodone/acetaminophen, for 14 days postsurgery. Current Medical Research and Opinion 30:12, pages 2571-2578.
Read now
Read now
Y. K. Lee, J. S. Ko, H. Y. Rhim, E. J. Lee, K. Karcher, H. Li, D. Shapiro & H. S. Lee. (2014) Acute postoperative pain relief with immediate-release tapentadol: randomized, double-blind, placebo-controlled study conducted in South Korea. Current Medical Research and Opinion 30:12, pages 2561-2570.
Read now
Read now
Robert B. Raffa. (2014) On subclasses of opioid analgesics. Current Medical Research and Opinion 30:12, pages 2579-2584.
Read now
Read now
Neil Singla, Thomas Barrett, Lisa Sisk, Kenneth Kostenbader, Jim Young & Michael Giuliani. (2014) A randomized, double-blind, placebo-controlled study of the efficacy and safety of MNK-795, a dual-layer, biphasic, immediate-release and extended-release combination analgesic for acute pain. Current Medical Research and Opinion 30:3, pages 349-359.
Read now
Read now
Joseph V. Pergolizzi$suffix/text()$suffix/text(), Marco Pappagallo, JoAnn LeQuang, Sumedha Labhsetwar & Robert Taylor$suffix/text()$suffix/text(). (2014) New Health Care Measures: Emphasis on Better Management of Postsurgical Pain and Postoperative Nausea and Vomiting. Hospital Practice 42:1, pages 65-74.
Read now
Read now
Nalini Vadivelu, Yili Huang, Brian Mirante, Michael Jacoby, Ferne R Braveman, Roberta L Hines & Raymond Sinatra. (2013) Patient considerations in the use of tapentadol for moderate to severe pain. Drug, Healthcare and Patient Safety 5, pages 151-159.
Read now
Read now
Roy Altman, Stephen Daniels & Clarence L. Young. (2013) Indomethacin Submicron Particle Capsules Provide Effective Pain Relief in Patients with Acute Pain: A Phase 3 Study. The Physician and Sportsmedicine 41:4, pages 7-15.
Read now
Read now
Allan Gibofsky, Stephen Silberstein, Charles Argoff, Stephen Daniels, Steve Jensen & Clarence L. Young. (2013) Lower-Dose Diclofenac Submicron Particle Capsules Provide Early and Sustained Acute Patient Pain Relief in a Phase 3 Study. Postgraduate Medicine 125:5, pages 130-138.
Read now
Read now
Jay Lin, Wing Chow, Myoung S. Kim & Marcia F. T. Rupnow. (2013) Real-world treatment pattern and outcomes among patients who took tapentadol IR or oxycodone IR. Journal of Medical Economics 16:5, pages 685-690.
Read now
Read now
Craig T Hartrick & Jose Rafael Rodríguez Hernandez. (2012) Tapentadol for pain: a treatment evaluation. Expert Opinion on Pharmacotherapy 13:2, pages 283-286.
Read now
Read now
Stephen E. Daniels, Ron J. Spivey, Sonia Singla, Michael Golf & Francis J. Clark. (2011) Efficacy and safety of oxycodone HCl/niacin tablets for the treatment of moderate-to-severe postoperative pain following bunionectomy surgery. Current Medical Research and Opinion 27:3, pages 593-603.
Read now
Read now
Marc Afilalo, Jens-Ulrich Stegmann & David Upmalis. (2010) Tapentadol immediate release: a new treatment option for acute pain management. Journal of Pain Research 3, pages 1-9.
Read now
Read now
Robert Buynak, Douglas Y Shapiro, Akiko Okamoto, Ilse Van Hove, Christine Rauschkolb, Achim Steup, Bernd Lange, Claudia Lange & Mila Etropolski. (2010) Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study. Expert Opinion on Pharmacotherapy 11:11, pages 1787-1804.
Read now
Read now
Keith A. Candiotti & Melvin C. Gitlin. (2010) Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?. Current Medical Research and Opinion 26:7, pages 1677-1684.
Read now
Read now
Craig T Hartrick. (2010) Tapentadol immediate-release for acute pain. Expert Review of Neurotherapeutics 10:6, pages 861-869.
Read now
Read now
Craig T Hartrick. (2009) Tapentadol immediate release for the relief of moderate-to-severe acute pain. Expert Opinion on Pharmacotherapy 10:16, pages 2687-2696.
Read now
Read now
Articles from other publishers (68)
Lorenzo Franco-de la Torre, Eduardo Gómez-Sánchez, Othoniel Hugo Aragon-Martinez, Adriana Hernández-Gómez, Diana Laura Franco-González, Juan Manuel Guzmán-Flores, Angel Josabad Alonso-Castro, Vinicio Granados-Soto & Mario Alberto Isiordia-Espinoza. (2023) Analgesic Efficacy and Safety of Tapentadol Immediate Release in Bunionectomy: A Meta-Analysis. Pharmaceuticals 16:9, pages 1287.
Crossref
Crossref
Jim JonesDarin J. CorrellSandra M. LechnerIna JazicXiaopeng MiaoDavid ShawChristopher SimardJeremiah D. OsteenBrian HareAlina BeatonTodd BertochAsokumar BuvanendranAshraf S. HabibLois J. PizziRichard A. PollakScott G. WeinerCarmen BozicPaul NegulescuPaul F. White. (2023)
Selective Inhibition of Na
V
1.8 with VX-548 for Acute Pain
. New England Journal of Medicine 389:5, pages 393-405.
Crossref
Crossref
Alessandra Oliveira Silva, Danielle Aparecida de Oliveira Marrafon, Ana Flávia Amorim, Carlos Marcelo de Barros, Ricardo Radighieri Rascado, Carla Speroni Ceron, Tiago Marques dos Reis, Márcia Helena MIranda Cardoso Podestá, Daniel Augusto de Faria Almeida, Larissa Helena Torres & Marília Gabriella Alves Goulart Pereira. (2023) Tapentadol, an opioid as a strategy for the treatment of chronic pain? A narrative review. Journal of Pharmaceutical and Biological Sciences 11:1, pages 18-25.
Crossref
Crossref
S Naveen, P Elango & Ramya S. (2023) An Open-Label, Randomized, Parallel-Group Study to Assess the Safety, Efficacy, and Tolerability of Tapentadol Versus Tramadol in Outpatients with Moderate to Severe Chronic Low Back Pain at a Tertiary Care Hospital in South India. Biomedical and Pharmacology Journal 16:2, pages 1037-1046.
Crossref
Crossref
Jennifer Mirabella, Deepa Ravi, Angela L. Chiew, Nicholas A. Buckley & Betty S. Chan. (2022) Prescribing trend of tapentadol in a Sydney local health district. British Journal of Clinical Pharmacology 88:9, pages 3929-3935.
Crossref
Crossref
Jennifer A Stevens & Bernadette R Findlay. (2022) How to close the gaps between evidence and practice for perioperative opioids. Anaesthesia and Intensive Care 50:1-2, pages 44-51.
Crossref
Crossref
Michał Jan Stasiowski, Aleksandra Pluta, Anita Lyssek-Boroń, Seweryn Król, Lech Krawczyk, Ewa Niewiadomska, Jakub Żak, Magdalena Kawka, Dariusz Dobrowolski, Beniamin Oskar Grabarek, Izabela Szumera, Michael Janusz Koss, Anna Missir, Robert Rejdak & Przemysław Jałowiecki. (2022) Adverse Events during Vitreoretinal Surgery under Adequacy of Anesthesia Guidance—Risk Factor Analysis. Pharmaceuticals 15:2, pages 237.
Crossref
Crossref
V. V. Nikoda. (2021) Tapentadol in acute pain: a review of the results of international studies. Modern Rheumatology Journal 15:4, pages 113-119.
Crossref
Crossref
M.M. Pylypenko & M.V. Bondar. (2021) Інтраопераційне анестезіологічне забезпечення, післяопераційне знеболювання та післяопераційна профілактика нудоти і блювання в разі гострої кишкової непрохідності (клінічна лекція). EMERGENCY MEDICINE 17:2, pages 28-33.
Crossref
Crossref
Torbjørn Rian, Eirik Skogvoll, Janne Hofstad, Lise Høvik, Siri B. Winther, Vigdis Schnell Husby, Jomar Klaksvik, Tarjei Egeberg, Kari Sand, Pål Klepstad & Tina Strømdal Wik. (2021) Tapentadol vs oxycodone for postoperative pain treatment the first 7 days after total knee arthroplasty: a randomized clinical trial. Pain 162:2, pages 396-404.
Crossref
Crossref
Bart J Morlion, César Margarit, Imane Wild, Ravi Karra, Hiltrud Liedgens, Melanie Sohns & Gabriele Finco. (2021) Bone fractures in patients using tapentadol or oxycodone: an exploratory US claims database study. Pain Management 11:1, pages 39-47.
Crossref
Crossref
Katarzyna Korwin-Kochanowska, Arnaud Potié, Kariem El-Boghdadly, Narinder Rawal, Girish Joshi & Eric Albrecht. (2020) PROSPECT guideline for hallux valgus repair surgery: a systematic review and procedure‐specific postoperative pain management recommendations. Regional Anesthesia & Pain Medicine 45:9, pages 702-708.
Crossref
Crossref
Xinyi Wang, Sujita W. Narayan, Jonathan Penm & Asad E. Patanwala. (2020) Efficacy and Safety of Tapentadol Immediate Release for Acute Pain. The Clinical Journal of Pain 36:5, pages 399-409.
Crossref
Crossref
John R Zuniga, Athena S Papas, Stephen E Daniels, Kyle Patrick, Derek D Muse, Daniel Oreadi, Helen E Giannakopoulos, Eric J Granquist, Lawrence M Levin, Joli C Chou, Hilda Maibach & Bernard P Schachtel. (2019) Prevention of Opioid-Induced Nausea and Vomiting During Treatment of Moderate to Severe Acute Pain: A Randomized Placebo-Controlled Trial Comparing CL-108 (Hydrocodone 7.5 mg/Acetaminophen 325 mg/Rapid-Release, Low-Dose Promethazine 12.5 mg) with Conventional Hydrocodone 7.5 mg/Acetaminophen 325 mg. Pain Medicine 20:12, pages 2528-2538.
Crossref
Crossref
Andrew Iskander & Tong J. Gan. (2018) Novel analgesics in ambulatory surgical patients. Current Opinion in Anaesthesiology 31:6, pages 685-692.
Crossref
Crossref
Yingchao Li, Yongjun Wang, Ran Zhang, Cuiru Liu, Yue Wei, Jin Sun, Zhonggui He, Youjun Xu & Tianhong Zhang. (2018) Improving the oral bioavailability of tapentadol via a carbamate prodrug approach: synthesis, bioactivation, and pharmacokinetics. Drug Delivery and Translational Research 8:5, pages 1335-1344.
Crossref
Crossref
Mark Holtsman & Charity Hale. 2018. Essentials of Pain Medicine. Essentials of Pain Medicine
385
388.e1
.
Ariane Stollenwerk, Melanie Sohns, Fabian Heisig, Christian Elling & Detlef von Zabern. (2017) Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic. Advances in Therapy 35:1, pages 12-30.
Crossref
Crossref
Neil K. Singla, Diana S. Meske & Paul J. Desjardins. (2017) Exploring the Interplay between Rescue Drugs, Data Imputation, and Study Outcomes: Conceptual Review and Qualitative Analysis of an Acute Pain Data Set. Pain and Therapy 6:2, pages 165-175.
Crossref
Crossref
Alberto Carmona-Bayonas, Paula Jiménez Fonseca & Juan Virizuela Echaburu. (2017) Tapentadol for Cancer Pain Management: A Narrative Review. Pain Practice 17:8, pages 1075-1088.
Crossref
Crossref
Theresa Mallick‐Searle & Mechele Fillman. (2017) The pathophysiology, incidence, impact, and treatment of opioid‐induced nausea and vomiting. Journal of the American Association of Nurse Practitioners 29:11, pages 704-710.
Crossref
Crossref
Nalini Vadivelu, Daniel Chang, Erik M. Helander, Gregory J. Bordelon, Alice Kai, Alan D. Kaye, Dora Hsu, Daniel Bang & Inderjeet Julka. (2017) Ketorolac, Oxymorphone, Tapentadol, and Tramadol. Anesthesiology Clinics 35:2, pages e1-e20.
Crossref
Crossref
Jing-Ping Xiao, Ai-Ling Li, Bi-Min Feng, Yun Ye & Guo-Jun Wang. (2017) Efficacy and Safety of Tapentadol Immediate Release Assessment in Treatment of Moderate to Severe Pain: A Systematic Review and Meta-Analysis. Pain Medicine 18:1, pages 14-24.
Crossref
Crossref
William L. Hasler. 2017. Nausea and Vomiting. Nausea and Vomiting
119
137
.
Elizabeth Marrett, Winghan Jacqueline Kwong, Feride Frech & Chunlin Qian. (2016) Health Care Utilization and Costs Associated with Nausea and Vomiting in Patients Receiving Oral Immediate-Release Opioids for Outpatient Acute Pain Management. Pain and Therapy 5:2, pages 215-226.
Crossref
Crossref
Stephen A. Cooper, Paul J. Desjardins, Dennis C. Turk, Robert H. Dworkin, Nathaniel P. Katz, Henrik Kehlet, Jane C. Ballantyne, Laurie B. Burke, Eugene Carragee, Penney Cowan, Scott Croll, Raymond A. Dionne, John T. Farrar, Ian Gilron, Debra B. Gordon, Smriti Iyengar, Gary W. Jay, Eija A. Kalso, Robert D. Kerns, Michael P. McDermott, Srinivasa N. Raja, Bob A. Rappaport, Christine Rauschkolb, Mike A. Royal, Märta Segerdahl, Joseph W. Stauffer, Knox H. Todd, Geertrui F. Vanhove, Mark S. Wallace, Christine West, Richard E. White & Christopher Wu. (2016) Research design considerations for single-dose analgesic clinical trials in acute pain. Pain 157:2, pages 288-301.
Crossref
Crossref
Robert Buynak, Stephen A. Rappaport, Kevin Rod, Pierre Arsenault, Fabian Heisig, Christine Rauschkolb & Mila Etropolski. (2015) Long-term Safety and Efficacy of Tapentadol Extended Release Following up to 2 Years of Treatment in Patients With Moderate to Severe, Chronic Pain: Results of an Open-label Extension Trial. Clinical Therapeutics 37:11, pages 2420-2438.
Crossref
Crossref
James A. Bolognese, Ruth Ann Subach & Franck Skobieranda. (2015) Evaluation of an Adaptive Maximizing Design Study Based on Clinical Utility Versus Morphine for TRV130 Proof-of-Concept and Dose-Regimen Finding in Patients With Postoperative Pain After Bunionectomy. Therapeutic Innovation & Regulatory Science 49:5, pages 756-766.
Crossref
Crossref
S. Ramaswamy, S. Chang & V. Mehta. (2015) Tapentadol - the evidence so far. Anaesthesia 70:5, pages 518-522.
Crossref
Crossref
Shalini Dhir, Rakesh V. Sondekoppam & Sugantha Ganapathy. 2015. Trauma Anesthesia. Trauma Anesthesia
244
266
.
. 2015. Trauma Anesthesia. Trauma Anesthesia
137
352
.
Qutaiba Amir Tawfic & Ali S Faris. (2015) Acute pain service: past, present and future. Pain Management 5:1, pages 47-58.
Crossref
Crossref
Emily C. McNaughton, Ryan A. Black, Sarah E. Weber & Stephen F. Butler. (2015) Assessing Abuse Potential of New Analgesic Medications Following Market Release: An Evaluation of Internet Discussion of Tapentadol Abuse. Pain Medicine 16:1, pages 131-140.
Crossref
Crossref
Stephen F. Butler, Emily C. McNaughton & Ryan A. Black. (2015) Tapentadol Abuse Potential: A Postmarketing Evaluation Using a Sample of Individuals Evaluated for Substance Abuse Treatment. Pain Medicine 16:1, pages 119-130.
Crossref
Crossref
Manuel J. Sánchez del Águila, Michael Schenk, Kai-Uwe Kern, Tanja Drost & Ilona Steigerwald. (2015) Practical Considerations for the Use of Tapentadol Prolonged Release for the Management of Severe Chronic Pain. Clinical Therapeutics 37:1, pages 94-113.
Crossref
Crossref
Neil K. Singla, Derek D. Muse, Mark A. Evashenk & Pamela P. Palmer. (2014) A dose-finding study of sufentanil sublingual microtablets for the management of postoperative bunionectomy pain. Journal of Trauma and Acute Care Surgery 77:3, pages S198-S203.
Crossref
Crossref
Keiichiro Imanaka, Yushin Tominaga, Mila Etropolski, Hiroki Ohashi, Keiichiro Hirose & Taka Matsumura. (2014) Ready Conversion of Patients with Well-Controlled, Moderate to Severe, Chronic Malignant Tumor–related Pain on Other Opioids to Tapentadol Extended Release. Clinical Drug Investigation 34:7, pages 501-511.
Crossref
Crossref
Neil K. Singla, Paul J. Desjardins & Phoebe D. Chang. (2014) A comparison of the clinical and experimental characteristics of four acute surgical pain models: Dental extraction, bunionectomy, joint replacement, and soft tissue surgery. Pain 155:3, pages 441-456.
Crossref
Crossref
Edward Michna, Wendy Y. Cheng, Caroline Korves, Howard Birnbaum, Ryan Andrews, Zhou Zhou, Ashish V. Joshi, David Schaaf, Jack Mardekian & Mei Sheng. (2014) Systematic Literature Review and Meta-Analysis of the Efficacy and Safety of Prescription Opioids, Including Abuse-Deterrent Formulations, in Non-Cancer Pain Management. Pain Medicine 15:1, pages 79-92.
Crossref
Crossref
Sonia Torres-Sanchez, Cristina Alba-Delgado, Meritxell Llorca-Torralba, Juan A. Mico & Esther Berrocoso. (2013) Effect of tapentadol on neurons in the locus coeruleus. Neuropharmacology 72, pages 250-258.
Crossref
Crossref
Gary J VorsangerJean Farrell, Jim Xiang, Wing Chow, Bruce L Moskovitz & Norman R Rosenthal. (2013) Tapentadol, oxycodone or placebo for acute pain of vertebral compression fractures: a randomized Phase IIIb study. Pain Management 3:2, pages 109-118.
Crossref
Crossref
Xu Steven Xu, Mila Etropolski, David Upmalis, Akiko Okamoto, Rachel Lin & Partha Nandy. (2012) Pharmacokinetic and Pharmacodynamic Modeling of Opioid-Induced Gastrointestinal Side Effects in Patients Receiving Tapentadol IR and Oxycodone IR. Pharmaceutical Research 29:9, pages 2555-2564.
Crossref
Crossref
M. Giorgi, A. Meizler & P.C. Mills. (2012) Quantification of tapentadol in canine plasma by HPLC with spectrofluorimetric detection: Development and validation of a new methodology. Journal of Pharmaceutical and Biomedical Analysis 67-68, pages 148-153.
Crossref
Crossref
I. D. Jeong, M. Camilleri, A. Shin, J. Iturrino, A. Boldingh, I. Busciglio, D. Burton, M. Ryks, D. Rhoten & A. R. Zinsmeister. (2012) A randomised, placebo‐controlled trial comparing the effects of tapentadol and oxycodone on gastrointestinal and colonic transit in healthy humans. Alimentary Pharmacology & Therapeutics 35:9, pages 1088-1096.
Crossref
Crossref
Joseph Pergolizzi, Cayetano Alegre, David Blake, Jaime Calvo Alén, Roberto Caporali, Hans‐Raimund Casser, Gerardo Correa‐Illanes, Pedro Fernandes, Eugenio Galilea, Richard Jany, Anthony Jones, Othmane Mejjad, Jadranka Morovic‐Vergles, Ángel Oteo Álvaro, Francisco J. Radrigán Araya, Maria Eugénia C. Simões & Generoso Uomo. (2011) Current Considerations for the Treatment of Severe Chronic Pain: The Potential for Tapentadol. Pain Practice 12:4, pages 290-306.
Crossref
Crossref
. (2012) Clinical Efficacy and Safety of Tapentadol Immediate Release in the Postoperative Setting. Journal of the American Podiatric Medical Association 102:2, pages 139-148.
Crossref
Crossref
Victor Mendis. (2012) Role of tapentadol in pain management. British Journal of Hospital Medicine 73:3, pages 143-147.
Crossref
Crossref
M. Merker, G. Dinges, T. Koch, P. Kranke & A.M. Morin. (2012) Unerwünschte Nebenwirkungen von Tapentadol im Vergleich zu OxycodonUndesired side effects of tapentadol in comparison to oxycodone. Der Schmerz 26:1, pages 16-26.
Crossref
Crossref
&NA;. (2011) Tapentadol immediate- and extended-release: a guide to its use in acute and chronic pain. Drugs & Therapy Perspectives 27:12, pages 1-6.
Crossref
Crossref
Chris Pasero. (2011) Tapentadol for Multimodal Pain Management. Journal of PeriAnesthesia Nursing 26:5, pages 343-346.
Crossref
Crossref
Michael Golf, Stephen E. Daniels & Erol Onel. (2011) A phase 3, randomized, placebo-controlled trial of DepoFoam® bupivacaine (extended-release bupivacaine local analgesic) in bunionectomy. Advances in Therapy 28:9, pages 776-788.
Crossref
Crossref
Craig T. Hartrick & Richard J. Rozek. (2011) Tapentadol in Pain Management. CNS Drugs 25:5, pages 359-370.
Crossref
Crossref
Mila Etropolski, Kathleen Kelly, Akiko Okamoto & Christine Rauschkolb. (2011) Comparable efficacy and superior gastrointestinal tolerability (nausea, vomiting, constipation) of tapentadol compared with oxycodone hydrochloride. Advances in Therapy 28:5, pages 401-417.
Crossref
Crossref
Gene-Siew NGIAN, Emma K. GUYMER & Geoffrey O. LITTLEJOHN. (2011) The use of opioids in fibromyalgia. International Journal of Rheumatic Diseases 14:1, pages 6-11.
Crossref
Crossref
John B. Leslie, Eugene R. Viscusi, Joseph V. Pergolizzi & Sunil J. Panchal. (2011) Anesthetic Routines: The Anesthesiologist's Role in GI Recovery and Postoperative Ileus. Advances in Preventive Medicine 2011, pages 1-10.
Crossref
Crossref
Michele L Matthews & Richard Lufkin. (2011) Tapentadol: A Novel, Centrally Acting Analgesic for Moderate-to-Severe Acute Pain. Journal of Pharmacy Technology 27:1, pages 27-34.
Crossref
Crossref
Stephen E. Daniels, Donald P. Bandy, Steven E. Christensen, Judith Boice, Maria C. Losada, Hui Liu, Anish Mehta & Paul M. Peloso. (2011) Evaluation of the Dose Range of Etoricoxib in an Acute Pain Setting Using the Postoperative Dental Pain Model. The Clinical Journal of Pain 27:1, pages 1-8.
Crossref
Crossref
Lucy A. Bee, Kirsty Bannister, Wahida Rahman & Anthony H. Dickenson. (2011) Mu-opioid and noradrenergic α2-adrenoceptor contributions to the effects of tapentadol on spinal electrophysiological measures of nociception in nerve-injured rats. Pain 152:1, pages 131-139.
Crossref
Crossref
Mark Holtsman & Barth L. Wilsey. 2011. Essentials of Pain Medicine. Essentials of Pain Medicine
97
100
.
Razmic S. GregorianJr.Jr., Alexander Gasik, Winghan Jacqueline Kwong, Simon Voeller & Shane Kavanagh. (2010) Importance of Side Effects in Opioid Treatment: A Trade-Off Analysis With Patients and Physicians. The Journal of Pain 11:11, pages 1095-1108.
Crossref
Crossref
Dan Froicu & Raymond S. Sinatra. 2010. The Essence of Analgesia and Analgesics. The Essence of Analgesia and Analgesics
143
146
.
Michael P. Nett. (2010) Postoperative Pain Management. Orthopedics 33:9, pages 23-26.
Crossref
Crossref
James E. Frampton. (2010) Tapentadol Immediate Release. Drugs 70:13, pages 1719-1743.
Crossref
Crossref
James E. Wild, Stefan Grond, Brigitte Kuperwasser, Jane Gilbert, Bettyanne McCann, Bernd Lange, Achim Steup, Thomas Häufel, Mila S. Etropolski, Christine Rauschkolb & Robert Lange. (2010) Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain. Pain Practice 10:5, pages 416-427.
Crossref
Crossref
Carla McSpadden, Bruce A. Ferrell & Polly Robinson. (2010) Pain Management in Long-Term Care: Practical Considerations and New Direction. The Consultant Pharmacist 25:0, pages 1-26.
Crossref
Crossref
J. Schneider, U. Jahnel & K. Linz. (2010) Neutral effects of the novel analgesic tapentadol on cardiac repolarization due to mixed ion channel inhibitory activities. Drug Development Research 71:3, pages 197-208.
Crossref
Crossref
Thomas Christoph, Jean De Vry & Thomas M. Tzschentke. (2010) Tapentadol, but not morphine, selectively inhibits disease-related thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Neuroscience Letters 470:2, pages 91-94.
Crossref
Crossref
Howard S Smith. (2009) Future of minimizing opioid adverse effects while maintaining or improving opioid-related analgesia. Therapy 6:5, pages 667-683.
Crossref
Crossref